<!DOCTYPE html SYSTEM "about:legacy-compat">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><style type="text/css">
				table.labtable {width:100%;border:1px solid #000;border-collapse:collapse;}
				input.labinput {width: 100%; box-sizing: border-box;-webkit-box-sizing:border-box; -moz-box-sizing: border-box;}
				select.labselect {width: 100%; box-sizing: border-box;-webkit-box-sizing:border-box; -moz-box-sizing: border-box;} 
				td.labcell{ border:1px solid;vertical-align:top; font-size:8pt;}
				td.labcelldisabled{ border:1px solid;vertical-align:top;  background:light-gray;}
th.blub { font-size:8pt;}
					
					p {text-align:left;font-size:8pt;font-family: verdana, arial, helvetica, sans-serif;}
					p.small {font-size:6pt;}
					p.annotation1 {text-align:center; font-size:8pt}
					p.annotation2 {text-align:left; font-size:8pt}
					p.audit {font-size:7pt; color:red}
					p.labValue {text-align:center; font-size:8pt; color:red}
					p.skipCondition {text-align:left; font-size:8pt; color:blue}
					p.rangeCheck {text-align:left; font-size:8pt; color:blue}
					p.event {text-align:left; font-size:8pt}
					p.study {text-align:center; font-size:14pt}
					p.form {text-align:center; font-size:14pt}
					p.group {text-align:center; font-size:12pt}
					p.head {text-align:left; font-weight:bold; font-size:16pt;}
					p.infob {font-weight:bold; font-size:8pt;}
					p.info {font-size:8pt;}

					a.small {font-family: verdana, arial, helvetica, sans-serif; font-size: 8pt; font-style: normal; line-height: normal; font-weight: normal; text-align: left; color:5a5aef}
					
					@page {size: 11.69in 8.27in;}
				}

				</style><title>Annotated eCRF</title></head><body><a name="top"></a><table width="1000" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="1000" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td style="width: 100%; border-right: none"><p class="head">Studies</p></td><td style="border-left: none"><img src="data:image/jpeg;base64,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" width="165px"></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="150"><p class="infob">Name</p></td><td><p class="infob">OID</p></td></tr><tr><td valign="top"><p class="info">ProTect</p></td><td valign="top"><p class="info"><a href="#PROTect01">PROTect01</a></p></td></tr></tbody></table><br></td></tr></tbody></table><table width="1000" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="20"></td><td><table width="100%" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td><a name="PROTect01"></a><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="5%"><a href="#top"><p class="annotation">Top</p></a></td><td width="65%"><p class="study"><b>Study: ProTect</b></p><p class="annotation1"><i>OID=PROTect01</i></p></td><td width="5%"><a href="#top"><p class="annotation">Top</p></a></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="150"><p class="infob"><b>Name</b></p></td><td><p class="info">ProTect</p></td></tr><tr><td><p class="infob"><b>Description</b></p></td><td><p class="info">Tablet iO6 Questionnaire</p></td></tr><tr><td><p class="infob"><b>Protocol-Nr</b></p></td><td><p class="info"></p></td></tr></tbody></table><br></td></tr></tbody></table><br><table width="1000" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="40"></td><td><table width="100%" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td><p class="head">MetaData</p></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="150"><p class="infob">Name</p></td><td><p class="infob">OID</p></td></tr><tr><td valign="top"><p class="info">PROTect</p></td><td valign="top"><p class="info"><a href="#PROTect01_001.000.000">001.000.000</a></p></td></tr></tbody></table><br></td></tr></tbody></table><table width="1000" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="60"></td><td><table width="100%" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td><a name="PROTect01_001.000.000"></a><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="5%"><a href="#PROTect01"><p class="annotation">Study</p></a></td><td width="65%"><p class="form"><b>MetaData: PROTect</b></p><p class="annotation1"><i>OID=001.000.000</i></p></td><td width="5%"><a href="#PROTect01"><p class="annotation">Study</p></a></td></tr></tbody></table></td></tr></tbody></table><br></td></tr></tbody></table><table width="1000" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="80"></td><td><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><p class="infob">Study Events:</p></td></tr><tr><td><p class="infob">Identifier</p></td><td><p class="infob">Mandatory</p></td><td><p class="infob">Forms</p></td></tr><tr><td rowspan="$Form_Count"><p class="info">Tablet Eingabemasken</p></td><td rowspan="$Form_Count"><p class="info">Yes</p></td><td><p class="info"><a href="#PROTect01_001.000.000_FD_QS_SCREEN1">Fragebogen</a></p></td><td><p class="info"><font color="blue"></font></p></td></tr><tr><td><p class="annotation1"></p></td></tr><tr><td rowspan="$Form_Count"><p class="info">Basisdokumentation</p></td><td rowspan="$Form_Count"><p class="info">Yes</p></td><td><p class="info"><a href="#PROTect01_001.000.000_FD_INFORMEDCONSENT">Basisdaten</a></p></td><td><p class="info"><font color="blue"></font></p></td></tr><tr><td rowspan="$Form_Count"></td><td rowspan="$Form_Count"></td><td><p class="info"><a href="#PROTect01_001.000.000_FD_MEDICATION">FD_MEDICATION</a></p></td><td><p class="info"><font color="blue"></font></p></td></tr></tbody></table><br><a name="Page Form: FD_QS_SCREEN1"></a><table style="border-color:#6699ff;  border-width: 5px; border-style:solid; border-radius: 5px" summary="Form FD_QS_SCREEN1" width="100%" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td><a name="PROTect01_001.000.000_FD_QS_SCREEN1"></a><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="5%"><a href="#PROTect01_001.000.000"><p class="annotation">MetaData</p></a></td><td width="65%"><p class="form"><b>Form: Fragebogen</b></p><p class="annotation1"><i>OID=FD_QS_SCREEN1</i></p></td><td width="5%"><a href="#PROTect01_001.000.000"><p class="annotation">MetaData</p></a></td></tr></tbody></table></td></tr></tbody></table><br></td></tr><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						&lt;p&gt;
                        Sehr geehrter Patient, sehr geehrte Patientin,
                        &lt;/p&gt;
                        &lt;p&gt;
                        wir möchten Sie bitten, die folgenden Fragen zu 
beantworten. Sie unterstützen uns dabei, Sie optimal zu behandeln.
                        &lt;/p&gt;
                        |
                        &lt;p&gt;
                        Drücken Sie "Weiter" zur Beantwortung der 
Fragen.
                        &lt;/p&gt;</b></p><p class="annotation1"><i>OID=IG_QS_WelcomeScreen, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN1, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Hatten Sie &lt;u&gt;in den letzten drei Tagen&lt;/u&gt; Fieber über 38°C?<br><i>OID = </i>ID_QS_FEVER<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN2, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Hatten Sie &lt;u&gt;in der letzten Woche&lt;/u&gt; deutliche Atemnot?<br><i>OID = </i>ID_QS_SOB<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Wie stark fühlen Sie sich dadurch belastet?<br><i>OID = </i>ID_QS_SOBSTRAIN<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_QS_RATING1"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_QS_RATING1</option><option value="1">1 - 1|leicht</option><option value="2">2 - 2</option><option value="3">3 - 3</option><option value="4">4 - 4</option><option value="5">5 - 5</option><option value="6">6 - 6</option><option value="7">7 - 7</option><option value="8">8 - 8</option><option value="9">9 - 9</option><option value="10">10 - 10|unerträglich</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN3, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Hatten Sie &lt;u&gt;seit der letzten Behandlung&lt;/u&gt; Durchfall?<br><i>OID = </i>ID_QS_DIARRHEA<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Wie häufig hatten Sie Durchfall pro Tag (maximal)?<br><i>OID = </i>ID_QS_DIARRHEACOUNT<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_QS_RATING2"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_QS_RATING2</option><option value="1">1 - 1</option><option value="2">2 - 2</option><option value="3">3 - 3</option><option value="4">4 - 4</option><option value="5">5 - 5</option><option value="6">6 - 6</option><option value="7">7 - 7</option><option value="8">8 - 8</option><option value="9">9 - 9</option><option value="10">10 - 10+|mehr als 10 mal</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN4, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Hatten Sie &lt;u&gt;in der letzten Woche&lt;/u&gt; Schmerzen?<br><i>OID = </i>ID_QS_PAIN<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Wie stark sind Ihre Schmerzen?<br><i>OID = </i>ID_QS_PAINDEGREE<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_QS_RATING1"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_QS_RATING1</option><option value="1">1 - 1|leicht</option><option value="2">2 - 2</option><option value="3">3 - 3</option><option value="4">4 - 4</option><option value="5">5 - 5</option><option value="6">6 - 6</option><option value="7">7 - 7</option><option value="8">8 - 8</option><option value="9">9 - 9</option><option value="10">10 - 10|unerträglich</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN5, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Hatten
 Sie &lt;u&gt;in den letzten drei Tagen&lt;/u&gt; Husten, Schnupfen, 
Halsschmerzen, Heiserkeit oder andere Symptome einer Erkältung?<br><i>OID = </i>ID_QS_COUGHCOLD<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN6, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Hatten Sie &lt;u&gt;in den letzten drei Tagen&lt;/u&gt; Brennen beim Wasserlassen oder einen vermehrten Harndrang?<br><i>OID = </i>ID_QS_BURNING<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN7, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Hatten Sie &lt;u&gt;seit der letzten Behandlung&lt;/u&gt; Kribbeln, Brennen oder Taubheitsgefühl in Füßen und/oder Händen?<br><i>OID = </i>ID_QS_NUMB<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Wie stark fühlen Sie sich dadurch belastet?<br><i>OID = </i>ID_QS_NUMBSTRAIN<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_QS_RATING1"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_QS_RATING1</option><option value="1">1 - 1|leicht</option><option value="2">2 - 2</option><option value="3">3 - 3</option><option value="4">4 - 4</option><option value="5">5 - 5</option><option value="6">6 - 6</option><option value="7">7 - 7</option><option value="8">8 - 8</option><option value="9">9 - 9</option><option value="10">10 - 10|unerträglich</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN8, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Hatten Sie &lt;u&gt;seit der letzten Behandlung&lt;/u&gt; Übelkeit?<br><i>OID = </i>ID_QS_NAUSEA<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Wie stark fühlen Sie sich dadurch belastet?<br><i>OID = </i>ID_QS_NAUSEASTRAIN<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_QS_RATING1"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_QS_RATING1</option><option value="1">1 - 1|leicht</option><option value="2">2 - 2</option><option value="3">3 - 3</option><option value="4">4 - 4</option><option value="5">5 - 5</option><option value="6">6 - 6</option><option value="7">7 - 7</option><option value="8">8 - 8</option><option value="9">9 - 9</option><option value="10">10 - 10|unerträglich</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN9, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Hatten Sie &lt;u&gt;seit der letzten Behandlung&lt;/u&gt; schmerzhafte Stellen im Mund?<br><i>OID = </i>ID_QS_MOUTH<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Wie stark fühlen Sie sich dadurch belastet?<br><i>OID = </i>ID_QS_MOUTHSTRAIN<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_QS_RATING1"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_QS_RATING1</option><option value="1">1 - 1|leicht</option><option value="2">2 - 2</option><option value="3">3 - 3</option><option value="4">4 - 4</option><option value="5">5 - 5</option><option value="6">6 - 6</option><option value="7">7 - 7</option><option value="8">8 - 8</option><option value="9">9 - 9</option><option value="10">10 - 10|unerträglich</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN10, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Sind &lt;u&gt;seit der letzten Behandlung&lt;/u&gt; Hautveränderungen aufgetreten?<br><i>OID = </i>ID_QS_SKIN<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Wie stark fühlen Sie sich dadurch belastet?<br><i>OID = </i>ID_QS_SKINSTRAIN<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_QS_RATING1"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_QS_RATING1</option><option value="1">1 - 1|leicht</option><option value="2">2 - 2</option><option value="3">3 - 3</option><option value="4">4 - 4</option><option value="5">5 - 5</option><option value="6">6 - 6</option><option value="7">7 - 7</option><option value="8">8 - 8</option><option value="9">9 - 9</option><option value="10">10 - 10|unerträglich</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b></b></p><p class="annotation1"><i>OID=IG_QS_SCREEN11, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Kennen Sie ihr aktuelles Gewicht?<br><i>OID = </i>ID_QS_WEIGHT_YN<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_GL_YN"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_GL_YN</option><option value="y">y - Ja</option><option value="n">n - Nein</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Wie viel wiegen Sie aktuell [kg]?<br><i>OID = </i>ID_QS_WEIGHT<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="" size="3" maxlength="3" type="text"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br></td></tr></tbody></table><br><a name="Page Form: FD_INFORMEDCONSENT"></a><table style="border-color:#6699ff;  border-width: 5px; border-style:solid; border-radius: 5px" summary="Form FD_INFORMEDCONSENT" width="100%" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td><a name="PROTect01_001.000.000_FD_INFORMEDCONSENT"></a><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="5%"><a href="#PROTect01_001.000.000"><p class="annotation">MetaData</p></a></td><td width="65%"><p class="form"><b>Form: Basisdaten</b></p><p class="annotation1"><i>OID=FD_INFORMEDCONSENT</i></p></td><td width="5%"><a href="#PROTect01_001.000.000"><p class="annotation">MetaData</p></a></td></tr></tbody></table></td></tr></tbody></table><br></td></tr><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Patientendaten</b></p><p class="annotation1"><i>OID=IG_DS_ICONSENT, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Datum der Einwilligung<br><i>OID = </i>ID_DS_DSICDAT<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="XXX"><option value="1" selected="selected">1</option><option value="2">2</option><option value="3">3</option><option value="4">4</option><option value="5">5</option><option value="6">6</option><option value="7">7</option><option value="8">8</option><option value="9">9</option><option value="10">10</option><option value="11">11</option><option value="12">12</option><option value="13">13</option><option value="14">14</option><option value="15">15</option><option value="16">16</option><option value="17">17</option><option value="18">18</option><option value="19">19</option><option value="20">20</option><option value="21">21</option><option value="22">22</option><option value="23">23</option><option value="24">24</option><option value="25">25</option><option value="26">26</option><option value="27">27</option><option value="28">28</option><option value="29">29</option><option value="30">30</option><option value="31">31</option></select><select name="M123"><option value="1" selected="selected">Jan</option><option value="2">Feb</option><option value="3">Mar</option><option value="4">Apr</option><option value="5">May</option><option value="6">Jun</option><option value="7">Jul</option><option value="8">Aug</option><option value="9">Sep</option><option value="10">Oct</option><option value="11">Nov</option><option value="12">Dec</option></select><input name="YYYY" size="4" maxlength="4" type="text"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Geburtsjahr<br><i>OID = </i>ID_DM_BRTHYR<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="YYYY" size="4" maxlength="4" type="text"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Demographische Daten</b></p><p class="annotation1"><i>OID=IG_DM_DEMO, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Geschlecht<br><i>OID = </i>ID_DM_SEX<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_DM_SEX"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_DM_SEX</option><option value="f">f - weiblich</option><option value="m">m - männlich</option></select><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br></td></tr></tbody></table><br><a name="Page Form: FD_MEDICATION"></a><table style="border-color:#6699ff;  border-width: 5px; border-style:solid; border-radius: 5px" summary="Form FD_MEDICATION" width="100%" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="5" border="1"><tbody><tr><td><a name="PROTect01_001.000.000_FD_MEDICATION"></a><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td width="5%"><a href="#PROTect01_001.000.000"><p class="annotation">MetaData</p></a></td><td width="65%"><p class="form"><b>Form: Medikation: </b></p><p class="annotation1"><i>OID=FD_MEDICATION</i></p></td><td width="5%"><a href="#PROTect01_001.000.000"><p class="annotation">MetaData</p></a></td></tr></tbody></table></td></tr></tbody></table><br></td></tr><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Therapiedaten</b></p><p class="annotation1"><i>OID=IG_TU_TUMOR, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Tumorkategorie<br><i>OID = </i>ID_TU_TUCAT<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_TUCAT"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_TUCAT</option><option value="1">1 - solide</option><option value="2">2 - hämatologisch</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Indikation<br><i>OID = </i>ID_TU_TUENTITY<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_INDIKATION2"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_INDIKATION2</option><option value="1">1 - Harnblasenkarzinom</option><option value="2">2 - Kolorektales Karzinom</option><option value="3">3 - Gallenblasenkarzinom</option><option value="4">4 - Gehirntumor</option><option value="5">5 - HNO Karzinom</option><option value="6">6 - Magenkarzinom</option><option value="7">7 - Mammakarzinom</option><option value="8">8 - Melanom</option><option value="9">9 - Nierenzellkarzinom</option><option value="10">10 - NSCLC und SCLC</option><option value="11">11 - Ovarialkarzinom</option><option value="12">12 - Ösophaguskarzinom</option><option value="13">13 - Pankreaskarzinom</option><option value="14">14 - Prostatakarzinom</option><option value="15">15 - Sarkom</option><option value="16">16 - Schilddrüsenkarzinom</option><option value="30">30 - M. Hodgkin</option><option value="31">31 - Multiples Myelom</option><option value="32">32 - indolentes NHL</option><option value="33">33 - hochmalignes NHL</option><option value="34">34 - MDS</option><option value="35">35 - Myeloproliferative Erkrankung (ausser CML)</option><option value="36">36 - CML</option><option value="37">37 - CLL</option><option value="38">38 - akute Leukämie</option><option value="99">99 - andere</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_TU_TUOTHER<br><font color="red"></font></p></td><td width="250" valign="top"><p><textarea name="ID_TU_TUOTHER" rows="5" cols="40">    </textarea><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Intention<br><i>OID = </i>ID_TU_INTENTION<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_INTENTION"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_INTENTION</option><option value="1">1 - adjuvant</option><option value="2">2 - palliativ</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Therapielinie<br><i>OID = </i>ID_EX_THERLINE<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="CO_LINE"><option value="
							  		_blank			
								" selected="selected">
								Code List: CO_LINE</option><option value="1">1 - 1</option><option value="2">2 - 2</option><option value="3">3 - 3</option><option value="4">4 - 4</option><option value="5">5 - 5</option><option value="6">6 - 6</option></select><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Therapiedatum<br><i>OID = </i>ID_EX_EXSTDAT1<br><font color="red"></font></p></td><td width="250" valign="top"><p><select name="XXX"><option value="1" selected="selected">1</option><option value="2">2</option><option value="3">3</option><option value="4">4</option><option value="5">5</option><option value="6">6</option><option value="7">7</option><option value="8">8</option><option value="9">9</option><option value="10">10</option><option value="11">11</option><option value="12">12</option><option value="13">13</option><option value="14">14</option><option value="15">15</option><option value="16">16</option><option value="17">17</option><option value="18">18</option><option value="19">19</option><option value="20">20</option><option value="21">21</option><option value="22">22</option><option value="23">23</option><option value="24">24</option><option value="25">25</option><option value="26">26</option><option value="27">27</option><option value="28">28</option><option value="29">29</option><option value="30">30</option><option value="31">31</option></select><select name="M123"><option value="1" selected="selected">Jan</option><option value="2">Feb</option><option value="3">Mar</option><option value="4">Apr</option><option value="5">May</option><option value="6">Jun</option><option value="7">Jul</option><option value="8">Aug</option><option value="9">Sep</option><option value="10">Oct</option><option value="11">Nov</option><option value="12">Dec</option></select><input name="YYYY" size="4" maxlength="4" type="text"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Harnblasenkarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND001, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>5-FU<br><i>OID = </i>ID_EX_EXTRT002<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Atezolizumab<br><i>OID = </i>ID_EX_EXTRT012<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>BCG<br><i>OID = </i>ID_EX_EXTRT014<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Carboplatin<br><i>OID = </i>ID_EX_EXTRT026<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cisplatin<br><i>OID = </i>ID_EX_EXTRT032<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Docetaxel (Taxotere)<br><i>OID = </i>ID_EX_EXTRT045<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin<br><i>OID = </i>ID_EX_EXTRT046<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Gemcitabin<br><i>OID = </i>ID_EX_EXTRT064<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Methotrexat (MTX)<br><i>OID = </i>ID_EX_EXTRT085<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vinblastin<br><i>OID = </i>ID_EX_EXTRT136<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vinflunin<br><i>OID = </i>ID_EX_EXTRT138<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Kolorektales Karzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND002, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>5-FU<br><i>OID = </i>ID_EX_EXTRT002<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Aflibercept<br><i>OID = </i>ID_EX_EXTRT006<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Bevacizumab (Avastin)<br><i>OID = </i>ID_EX_EXTRT017<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Capecitabin (Xeloda)<br><i>OID = </i>ID_EX_EXTRT024<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cetuximab (Erbitux)<br><i>OID = </i>ID_EX_EXTRT030<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>FOLFIRI<br><i>OID = </i>ID_EX_EXTRT058<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>FOLFOX<br><i>OID = </i>ID_EX_EXTRT060<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>FOLFOXIRI<br><i>OID = </i>ID_EX_EXTRT061<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Irinotecan<br><i>OID = </i>ID_EX_EXTRT075<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Irinotecan Nanopartikel Albumin-gebunden, Nal-Iri<br><i>OID = </i>ID_EX_EXTRT076<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Mitomycin C<br><i>OID = </i>ID_EX_EXTRT086<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Oxaliplatin<br><i>OID = </i>ID_EX_EXTRT098<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Panitumumab<br><i>OID = </i>ID_EX_EXTRT102<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ramucirumab<br><i>OID = </i>ID_EX_EXTRT116<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>TAS-100<br><i>OID = </i>ID_EX_EXTRT123<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Gallenblasenkarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND003, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Gemcitabin<br><i>OID = </i>ID_EX_EXTRT064<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Oxaliplatin<br><i>OID = </i>ID_EX_EXTRT098<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Gehirntumor</b></p><p class="annotation1"><i>OID=IG_EX_EXIND004, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>5-FU<br><i>OID = </i>ID_EX_EXTRT002<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>ACNU (Nimustin)<br><i>OID = </i>ID_EX_EXTRT004<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>BCNU (Carmustin)<br><i>OID = </i>ID_EX_EXTRT015<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Bevacizumab (Avastin)<br><i>OID = </i>ID_EX_EXTRT017<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>CCNU (Lomustin)<br><i>OID = </i>ID_EX_EXTRT028<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cytarabin<br><i>OID = </i>ID_EX_EXTRT037<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Procarbazin<br><i>OID = </i>ID_EX_EXTRT113<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Temozolomid<br><i>OID = </i>ID_EX_EXTRT125<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vincristin<br><i>OID = </i>ID_EX_EXTRT137<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						HNO Karzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND005, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>5-FU<br><i>OID = </i>ID_EX_EXTRT002<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Carboplatin<br><i>OID = </i>ID_EX_EXTRT026<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cetuximab (Erbitux)<br><i>OID = </i>ID_EX_EXTRT030<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cisplatin<br><i>OID = </i>ID_EX_EXTRT032<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Docetaxel (Taxotere)<br><i>OID = </i>ID_EX_EXTRT045<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Methotrexat (MTX)<br><i>OID = </i>ID_EX_EXTRT085<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Magenkarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND006, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>5-FU<br><i>OID = </i>ID_EX_EXTRT002<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Capecitabin (Xeloda)<br><i>OID = </i>ID_EX_EXTRT024<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Carboplatin<br><i>OID = </i>ID_EX_EXTRT026<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cisplatin<br><i>OID = </i>ID_EX_EXTRT032<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Docetaxel (Taxotere)<br><i>OID = </i>ID_EX_EXTRT045<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Epirubicin<br><i>OID = </i>ID_EX_EXTRT051<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Leukovorin<br><i>OID = </i>ID_EX_EXTRT082<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Oxaliplatin<br><i>OID = </i>ID_EX_EXTRT098<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ramucirumab<br><i>OID = </i>ID_EX_EXTRT116<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Trastuzumab<br><i>OID = </i>ID_EX_EXTRT131<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Mammakarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND007, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>5-FU<br><i>OID = </i>ID_EX_EXTRT002<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Anastrozol<br><i>OID = </i>ID_EX_EXTRT010<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Bevacizumab (Avastin)<br><i>OID = </i>ID_EX_EXTRT017<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Capecitabin (Xeloda)<br><i>OID = </i>ID_EX_EXTRT024<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Carboplatin<br><i>OID = </i>ID_EX_EXTRT026<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cisplatin<br><i>OID = </i>ID_EX_EXTRT032<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cyclophosphamid (Endoxan)<br><i>OID = </i>ID_EX_EXTRT036<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Docetaxel (Taxotere)<br><i>OID = </i>ID_EX_EXTRT045<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin<br><i>OID = </i>ID_EX_EXTRT046<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin liposomal (Myocet)<br><i>OID = </i>ID_EX_EXTRT047<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin liposomal pegyliert (Caelyx)<br><i>OID = </i>ID_EX_EXTRT048<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Epirubicin<br><i>OID = </i>ID_EX_EXTRT051<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Eribulin<br><i>OID = </i>ID_EX_EXTRT052<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Etoposid<br><i>OID = </i>ID_EX_EXTRT054<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Everolimus<br><i>OID = </i>ID_EX_EXTRT055<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Exemestan<br><i>OID = </i>ID_EX_EXTRT056<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Fulvestrant<br><i>OID = </i>ID_EX_EXTRT062<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Gemcitabin<br><i>OID = </i>ID_EX_EXTRT064<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Goserelin (Zoladex)<br><i>OID = </i>ID_EX_EXTRT065<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Lapatinib<br><i>OID = </i>ID_EX_EXTRT078<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Letrozol<br><i>OID = </i>ID_EX_EXTRT081<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Leuprorelin<br><i>OID = </i>ID_EX_EXTRT083<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Methotrexat (MTX)<br><i>OID = </i>ID_EX_EXTRT085<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Mitomycin C<br><i>OID = </i>ID_EX_EXTRT086<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Mitoxantron<br><i>OID = </i>ID_EX_EXTRT087<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>MPA (Medroxyprogesteronacetat)<br><i>OID = </i>ID_EX_EXTRT088<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Navelbine<br><i>OID = </i>ID_EX_EXTRT089<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Paclitaxel (Taxol)<br><i>OID = </i>ID_EX_EXTRT099<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Paclitaxel, Nanopartikel Albumin-gebunden, Nab-Paclitaxel<br><i>OID = </i>ID_EX_EXTRT100<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Palbociclib (Ibrance)<br><i>OID = </i>ID_EX_EXTRT101<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pemetrexed<br><i>OID = </i>ID_EX_EXTRT106<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pertuzumab<br><i>OID = </i>ID_EX_EXTRT108<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Tamoxifen<br><i>OID = </i>ID_EX_EXTRT122<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>T-DM1 (Kadcyla)<br><i>OID = </i>ID_EX_EXTRT124<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Topotecan<br><i>OID = </i>ID_EX_EXTRT128<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Trastuzumab<br><i>OID = </i>ID_EX_EXTRT131<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vinorelbin<br><i>OID = </i>ID_EX_EXTRT139<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Melanom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND008, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Cobimetinib (Cotellic)<br><i>OID = </i>ID_EX_EXTRT034<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Dabrafenib (Tafinlar)<br><i>OID = </i>ID_EX_EXTRT038<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Dacarbazin<br><i>OID = </i>ID_EX_EXTRT039<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Interferon alfa-2b (IntronA)<br><i>OID = </i>ID_EX_EXTRT071<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ipilimumab (Yervoy)<br><i>OID = </i>ID_EX_EXTRT074<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Nivolumab (Opvidio)<br><i>OID = </i>ID_EX_EXTRT093<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pembrolizumab (Keytruda)<br><i>OID = </i>ID_EX_EXTRT105<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Temozolomid<br><i>OID = </i>ID_EX_EXTRT125<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Trametinib (Mekinist)<br><i>OID = </i>ID_EX_EXTRT130<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vemurafenib (Zelboraf)<br><i>OID = </i>ID_EX_EXTRT134<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Nierenzellkarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND009, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Axitinib<br><i>OID = </i>ID_EX_EXTRT013<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Bevacizumab (Avastin)<br><i>OID = </i>ID_EX_EXTRT017<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cabozantinib (Cometriq)<br><i>OID = </i>ID_EX_EXTRT023<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Everolimus<br><i>OID = </i>ID_EX_EXTRT055<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Interferon alpha<br><i>OID = </i>ID_EX_EXTRT072<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Interleukin (Hochdosis)<br><i>OID = </i>ID_EX_EXTRT073<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Lenvatinib (Lenvima)<br><i>OID = </i>ID_EX_EXTRT080<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Nivolumab (Opvidio)<br><i>OID = </i>ID_EX_EXTRT093<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pazopanib<br><i>OID = </i>ID_EX_EXTRT104<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pembrolizumab (Keytruda)<br><i>OID = </i>ID_EX_EXTRT105<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Sorafinib<br><i>OID = </i>ID_EX_EXTRT120<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Sunitinib<br><i>OID = </i>ID_EX_EXTRT121<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Temsirolimus<br><i>OID = </i>ID_EX_EXTRT126<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						NSCLC und SCLC</b></p><p class="annotation1"><i>OID=IG_EX_EXIND010, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Afatinib<br><i>OID = </i>ID_EX_EXTRT005<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Alectinib<br><i>OID = </i>ID_EX_EXTRT007<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Atezolizumab<br><i>OID = </i>ID_EX_EXTRT012<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Bevacizumab (Avastin)<br><i>OID = </i>ID_EX_EXTRT017<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Bleomycin<br><i>OID = </i>ID_EX_EXTRT018<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Carboplatin<br><i>OID = </i>ID_EX_EXTRT026<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ceritinib<br><i>OID = </i>ID_EX_EXTRT029<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cisplatin<br><i>OID = </i>ID_EX_EXTRT032<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Crizotinib<br><i>OID = </i>ID_EX_EXTRT035<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cyclophosphamid (Endoxan)<br><i>OID = </i>ID_EX_EXTRT036<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Docetaxel (Taxotere)<br><i>OID = </i>ID_EX_EXTRT045<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin<br><i>OID = </i>ID_EX_EXTRT046<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Epirubicin<br><i>OID = </i>ID_EX_EXTRT051<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Erlotinib<br><i>OID = </i>ID_EX_EXTRT053<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Etoposid<br><i>OID = </i>ID_EX_EXTRT054<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Gefitinib<br><i>OID = </i>ID_EX_EXTRT063<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Gemcitabin<br><i>OID = </i>ID_EX_EXTRT064<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ifosfamid<br><i>OID = </i>ID_EX_EXTRT069<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Navelbine<br><i>OID = </i>ID_EX_EXTRT089<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Necitumumab<br><i>OID = </i>ID_EX_EXTRT090<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Nintedanib<br><i>OID = </i>ID_EX_EXTRT092<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Nivolumab (Opvidio)<br><i>OID = </i>ID_EX_EXTRT093<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Osimertinib<br><i>OID = </i>ID_EX_EXTRT097<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Paclitaxel (Taxol)<br><i>OID = </i>ID_EX_EXTRT099<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Paclitaxel, Nanopartikel Albumin-gebunden, Nab-Paclitaxel<br><i>OID = </i>ID_EX_EXTRT100<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pembrolizumab (Keytruda)<br><i>OID = </i>ID_EX_EXTRT105<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pemetrexed<br><i>OID = </i>ID_EX_EXTRT106<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ramucirumab<br><i>OID = </i>ID_EX_EXTRT116<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Topotecan<br><i>OID = </i>ID_EX_EXTRT128<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Treosulfan<br><i>OID = </i>ID_EX_EXTRT132<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vinorelbin<br><i>OID = </i>ID_EX_EXTRT139<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Ovarialkarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND011, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Bevacizumab (Avastin)<br><i>OID = </i>ID_EX_EXTRT017<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Carboplatin<br><i>OID = </i>ID_EX_EXTRT026<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cisplatin<br><i>OID = </i>ID_EX_EXTRT032<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Docetaxel (Taxotere)<br><i>OID = </i>ID_EX_EXTRT045<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin liposomal pegyliert (Caelyx)<br><i>OID = </i>ID_EX_EXTRT048<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Gemcitabin<br><i>OID = </i>ID_EX_EXTRT064<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Olaparib (Lynparza)<br><i>OID = </i>ID_EX_EXTRT096<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Paclitaxel (Taxol)<br><i>OID = </i>ID_EX_EXTRT099<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Topotecan<br><i>OID = </i>ID_EX_EXTRT128<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Trabectedin (Yondelis)<br><i>OID = </i>ID_EX_EXTRT129<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Treosulfan<br><i>OID = </i>ID_EX_EXTRT132<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Ösophaguskarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND012, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>5-FU<br><i>OID = </i>ID_EX_EXTRT002<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Carboplatin<br><i>OID = </i>ID_EX_EXTRT026<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cisplatin<br><i>OID = </i>ID_EX_EXTRT032<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Docetaxel (Taxotere)<br><i>OID = </i>ID_EX_EXTRT045<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Gemcitabin<br><i>OID = </i>ID_EX_EXTRT064<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Paclitaxel (Taxol)<br><i>OID = </i>ID_EX_EXTRT099<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vinorelbin<br><i>OID = </i>ID_EX_EXTRT139<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Pankreaskarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND013, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>5-FU<br><i>OID = </i>ID_EX_EXTRT002<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Erlotinib<br><i>OID = </i>ID_EX_EXTRT053<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Folfirinox<br><i>OID = </i>ID_EX_EXTRT059<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Gemcitabin<br><i>OID = </i>ID_EX_EXTRT064<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Irinotecan<br><i>OID = </i>ID_EX_EXTRT075<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Irinotecan Nanopartikel Albumin-gebunden, Nal-Iri<br><i>OID = </i>ID_EX_EXTRT076<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Oxaliplatin<br><i>OID = </i>ID_EX_EXTRT098<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Paclitaxel, Nanopartikel Albumin-gebunden, Nab-Paclitaxel<br><i>OID = </i>ID_EX_EXTRT100<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Prostatakarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND014, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Abirateron Acetat (Zytiga)<br><i>OID = </i>ID_EX_EXTRT003<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cabazitaxel (Jevtana)<br><i>OID = </i>ID_EX_EXTRT022<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Degarelix (Firmagon)<br><i>OID = </i>ID_EX_EXTRT043<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Dexamethason<br><i>OID = </i>ID_EX_EXTRT044<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Docetaxel (Taxotere)<br><i>OID = </i>ID_EX_EXTRT045<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Enzalutamid (Xtandi)<br><i>OID = </i>ID_EX_EXTRT050<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Mitoxantron<br><i>OID = </i>ID_EX_EXTRT087<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Radium Ra223 dichlorid (Xofigo)<br><i>OID = </i>ID_EX_EXTRT115<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Sarkom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND015, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Schilddrüsenkarzinom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND016, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Cabozantinib (Cometriq)<br><i>OID = </i>ID_EX_EXTRT023<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Lenvatinib (Lenvima)<br><i>OID = </i>ID_EX_EXTRT080<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Radio-Jodtherapie<br><i>OID = </i>ID_EX_EXTRT114<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vandetanib (Caprelsa)<br><i>OID = </i>ID_EX_EXTRT133<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						M. Hodgkin</b></p><p class="annotation1"><i>OID=IG_EX_EXIND017, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Bleomycin<br><i>OID = </i>ID_EX_EXTRT018<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Brentuximab-Vedotin (Adcetris)<br><i>OID = </i>ID_EX_EXTRT021<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cyclophosphamid (Endoxan)<br><i>OID = </i>ID_EX_EXTRT036<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Dacarbazin<br><i>OID = </i>ID_EX_EXTRT039<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin<br><i>OID = </i>ID_EX_EXTRT046<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Etoposid<br><i>OID = </i>ID_EX_EXTRT054<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Nivolumab (Opvidio)<br><i>OID = </i>ID_EX_EXTRT093<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Prednison/Prednisolon<br><i>OID = </i>ID_EX_EXTRT112<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Procarbazin<br><i>OID = </i>ID_EX_EXTRT113<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Rituximab<br><i>OID = </i>ID_EX_EXTRT118<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Venetoclax<br><i>OID = </i>ID_EX_EXTRT135<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vinblastin<br><i>OID = </i>ID_EX_EXTRT136<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vincristin<br><i>OID = </i>ID_EX_EXTRT137<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Multiples Myelom</b></p><p class="annotation1"><i>OID=IG_EX_EXIND018, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Bendamustin<br><i>OID = </i>ID_EX_EXTRT016<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Bortezomib<br><i>OID = </i>ID_EX_EXTRT019<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Carfilzomib (Kyprolis)<br><i>OID = </i>ID_EX_EXTRT027<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cyclophosphamid (Endoxan)<br><i>OID = </i>ID_EX_EXTRT036<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Daratumomab (Darzalex)<br><i>OID = </i>ID_EX_EXTRT040<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Dexamethason<br><i>OID = </i>ID_EX_EXTRT044<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin<br><i>OID = </i>ID_EX_EXTRT046<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin liposomal pegyliert (Caelyx)<br><i>OID = </i>ID_EX_EXTRT048<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Elotuzumab (Emplicitit)<br><i>OID = </i>ID_EX_EXTRT049<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ixazomib<br><i>OID = </i>ID_EX_EXTRT077<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Lenalidomid<br><i>OID = </i>ID_EX_EXTRT079<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Melphalan<br><i>OID = </i>ID_EX_EXTRT084<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Panobinostat (Farydak)<br><i>OID = </i>ID_EX_EXTRT103<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pomalidomid (Imnovid)<br><i>OID = </i>ID_EX_EXTRT110<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Prednison/Prednisolon<br><i>OID = </i>ID_EX_EXTRT112<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Thalidomid<br><i>OID = </i>ID_EX_EXTRT127<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						indolentes NHL</b></p><p class="annotation1"><i>OID=IG_EX_EXIND019, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Bendamustin<br><i>OID = </i>ID_EX_EXTRT016<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Bortezomib<br><i>OID = </i>ID_EX_EXTRT019<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Chlorambucil<br><i>OID = </i>ID_EX_EXTRT031<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cladribin<br><i>OID = </i>ID_EX_EXTRT033<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cyclophosphamid (Endoxan)<br><i>OID = </i>ID_EX_EXTRT036<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin<br><i>OID = </i>ID_EX_EXTRT046<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Fludarabin<br><i>OID = </i>ID_EX_EXTRT057<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ibrutinib<br><i>OID = </i>ID_EX_EXTRT067<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Idelalisib<br><i>OID = </i>ID_EX_EXTRT068<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Lenalidomid<br><i>OID = </i>ID_EX_EXTRT079<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pentostatin<br><i>OID = </i>ID_EX_EXTRT107<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Prednison/Prednisolon<br><i>OID = </i>ID_EX_EXTRT112<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Rituximab<br><i>OID = </i>ID_EX_EXTRT118<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Temsirolimus<br><i>OID = </i>ID_EX_EXTRT126<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Venetoclax<br><i>OID = </i>ID_EX_EXTRT135<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vincristin<br><i>OID = </i>ID_EX_EXTRT137<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						hochmalignes NHL</b></p><p class="annotation1"><i>OID=IG_EX_EXIND020, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Ara-C<br><i>OID = </i>ID_EX_EXTRT011<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>BCNU (Carmustin)<br><i>OID = </i>ID_EX_EXTRT015<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Chlorambucil<br><i>OID = </i>ID_EX_EXTRT031<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cisplatin<br><i>OID = </i>ID_EX_EXTRT032<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cyclophosphamid (Endoxan)<br><i>OID = </i>ID_EX_EXTRT036<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Dexamethason<br><i>OID = </i>ID_EX_EXTRT044<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin<br><i>OID = </i>ID_EX_EXTRT046<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Etoposid<br><i>OID = </i>ID_EX_EXTRT054<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Gemcitabin<br><i>OID = </i>ID_EX_EXTRT064<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Melphalan<br><i>OID = </i>ID_EX_EXTRT084<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Methotrexat (MTX)<br><i>OID = </i>ID_EX_EXTRT085<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Mitoxantron<br><i>OID = </i>ID_EX_EXTRT087<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Oxaliplatin<br><i>OID = </i>ID_EX_EXTRT098<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Panobinostat (Farydak)<br><i>OID = </i>ID_EX_EXTRT103<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Pixantron<br><i>OID = </i>ID_EX_EXTRT109<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Prednison/Prednisolon<br><i>OID = </i>ID_EX_EXTRT112<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>R-DHAP<br><i>OID = </i>ID_EX_EXTRT117<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Rituximab<br><i>OID = </i>ID_EX_EXTRT118<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Venetoclax<br><i>OID = </i>ID_EX_EXTRT135<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vincristin<br><i>OID = </i>ID_EX_EXTRT137<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						MDS</b></p><p class="annotation1"><i>OID=IG_EX_EXIND021, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>5-Azacytidin<br><i>OID = </i>ID_EX_EXTRT001<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ara-C<br><i>OID = </i>ID_EX_EXTRT011<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Decitabin<br><i>OID = </i>ID_EX_EXTRT042<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Lenalidomid<br><i>OID = </i>ID_EX_EXTRT079<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						Myeloproliferative Erkrankung (ausser CML)</b></p><p class="annotation1"><i>OID=IG_EX_EXIND022, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Anagrelide<br><i>OID = </i>ID_EX_EXTRT009<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Hydroxyurea<br><i>OID = </i>ID_EX_EXTRT066<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Interferon alpha<br><i>OID = </i>ID_EX_EXTRT072<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ruxolitinib<br><i>OID = </i>ID_EX_EXTRT119<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						CML</b></p><p class="annotation1"><i>OID=IG_EX_EXIND023, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Bosutinib<br><i>OID = </i>ID_EX_EXTRT020<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Dasatinib<br><i>OID = </i>ID_EX_EXTRT041<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Hydroxyurea<br><i>OID = </i>ID_EX_EXTRT066<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Imatinib<br><i>OID = </i>ID_EX_EXTRT070<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Interferon alpha<br><i>OID = </i>ID_EX_EXTRT072<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Nilotinib<br><i>OID = </i>ID_EX_EXTRT091<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ponatinib<br><i>OID = </i>ID_EX_EXTRT111<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						CLL</b></p><p class="annotation1"><i>OID=IG_EX_EXIND024, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>Alemtuzumab<br><i>OID = </i>ID_EX_EXTRT008<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Bendamustin<br><i>OID = </i>ID_EX_EXTRT016<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Chlorambucil<br><i>OID = </i>ID_EX_EXTRT031<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Cyclophosphamid (Endoxan)<br><i>OID = </i>ID_EX_EXTRT036<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Doxorubicin<br><i>OID = </i>ID_EX_EXTRT046<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Fludarabin<br><i>OID = </i>ID_EX_EXTRT057<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ibrutinib<br><i>OID = </i>ID_EX_EXTRT067<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Idelalisib<br><i>OID = </i>ID_EX_EXTRT068<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Lenalidomid<br><i>OID = </i>ID_EX_EXTRT079<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Obinutuzumab<br><i>OID = </i>ID_EX_EXTRT094<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Ofatumumab<br><i>OID = </i>ID_EX_EXTRT095<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Prednison/Prednisolon<br><i>OID = </i>ID_EX_EXTRT112<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Rituximab<br><i>OID = </i>ID_EX_EXTRT118<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Venetoclax<br><i>OID = </i>ID_EX_EXTRT135<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>Vincristin<br><i>OID = </i>ID_EX_EXTRT137<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br><table width="100%" cellspacing="0" cellpadding="2" border="0"><tbody><tr><td><table width="100%" cellspacing="0" cellpadding="2" border="1"><tbody><tr valign="top"><td valign="top"><p class="group"><b>
					Group: 
						akute Leukämie</b></p><p class="annotation1"><i>OID=IG_EX_EXIND025, Repeating=No</i></p></td></tr><tr valign="top"><td valign="top"><table border="0"><tbody><tr valign="top"><td width="400" valign="top"><p>andere<br><i>OID = </i>ID_EX_EXTRT999<br><font color="red"></font></p></td><td width="250" valign="top"><p><input name="@OID" type="checkbox"><br></p></td><td valign="top"></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><br></td></tr></tbody></table><br></td></tr></tbody></table></body></html>